Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
14 Nov 2023
Historique:
received: 05 10 2023
revised: 09 11 2023
accepted: 11 11 2023
medline: 27 11 2023
pubmed: 24 11 2023
entrez: 24 11 2023
Statut: epublish

Résumé

The Health Assessment Questionnaire Disability Index (HAQ-DI) was completed with five visual analog scales to assess systemic sclerosis (SSc) called Scleroderma HAQ (SHAQ). We performed a validation of the European Portuguese version of SHAQ for patients with SSc. Patients with different forms of SSc from five Hospital Centers were invited. The reliability of the Portuguese SHAQ was evaluated by internal consistency and by test-retest reliability. Content validity was checked by two rheumatologists and by a panel of patients. Construct validity was assessed by structural validity and by known-groups hypothesis tests. Criterion validity was addressed with selected dimensions from the UCLA GIT 2.0, the SF-36v2, and the EuroQoL EQ-5D-5L. A total of 102 SSc patients agreed to participate, 31 of which answered to the retest. HAQ-DI demonstrated high internal consistency reliability (α = 0.866) and SHAQ also showed high test-retest reliability (ICC 0.61-0.95). We evidenced the unidimensionality of all VASs. HAQ-DI scores were worse in males, patients older than 65 years, and individuals with a diffuse form of SSc. Criterion validity was mainly evidenced through the correlation between the HAQ-DI and SF-36v2 physical summary measure (r = -0.688) and EQ-5D-5L index score (r = -0.723). Likewise, the SHAQ overall disease severity VAS was also correlated with SF-36v2 physical summary measure (r = -0.628). Mental score correlations were smaller. With the exception of the Raynaud's VAS, all the other VASs correlated well with similar clinical variables. This paper provides evidence to demonstrate how reliable and valid the European Portuguese version of SHAQ is, to be used in SSc patients to assess the clinical severity under the perspective of patients.

Identifiants

pubmed: 37998293
pii: ijerph20227062
doi: 10.3390/ijerph20227062
pmc: PMC10671070
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Arthritis Rheum. 1997 Nov;40(11):1984-91
pubmed: 9365087
J Clin Epidemiol. 2010 Jul;63(7):737-45
pubmed: 20494804
Ann Rheum Dis. 2011 Mar;70(3):476-81
pubmed: 21081523
J Rheumatol. 1982 Sep-Oct;9(5):789-93
pubmed: 7175852
Arthritis Rheum. 2009 Sep 15;61(9):1257-63
pubmed: 19714600
Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S14-8
pubmed: 16273780
Int J Rheum Dis. 2012 Jun;15(3):268-76
pubmed: 22709488
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
J Rheumatol. 2003 Jun;30(6):1253-8
pubmed: 12784399
Reumatismo. 2006 Apr-Jun;58(2):112-5
pubmed: 16829988
J Rheumatol. 2019 Jan;46(1):78-84
pubmed: 30442827
J Rheumatol. 2009 Apr;36(4):768-72
pubmed: 19228662
Arthritis Care Res. 1991 Mar;4(1):27-31
pubmed: 11188583
Curr Opin Rheumatol. 2013 Nov;25(6):700-6
pubmed: 24047604
Int J Environ Res Public Health. 2023 Jan 14;20(2):
pubmed: 36674306
Acta Med Port. 2000 Jan-Apr;13(1-2):55-66
pubmed: 11059056
Eur J Health Econ. 2023 Dec;24(9):1411-1420
pubmed: 36630005
Arthritis Rheum. 1980 Feb;23(2):137-45
pubmed: 7362664
Scand J Rheumatol. 2013;42(4):317-24
pubmed: 23442162
Clin Rheumatol. 2014 May;33(5):699-706
pubmed: 23975361
Clin Rheumatol. 2005 Feb;24(1):3-10
pubmed: 15674652
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
J Scleroderma Relat Disord. 2022 Feb;7(1):33-41
pubmed: 35386940
Rheumatology (Oxford). 2019 Nov 1;58(11):1985-1990
pubmed: 31056685
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Autoimmun Rev. 2013 Jan;12(3):340-54
pubmed: 22743034
Ann Med Interne (Paris). 2002 Jun;153(4):260-4
pubmed: 12218892
Arthritis Rheum. 2013 Nov;65(11):2737-47
pubmed: 24122180
Sao Paulo Med J. 2014;132(3):163-9
pubmed: 24788030
Qual Life Res. 2019 Dec;28(12):3163-3175
pubmed: 31201730
Scand J Gastroenterol. 2021 May;56(5):508-513
pubmed: 33689560
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
Clin Rheumatol. 2019 Jul;38(7):1917-1923
pubmed: 30840212

Auteurs

Inês Genrinho (I)

Rheumatology Department, Tondela Viseu Hospital Centre, 3504-509 Viseu, Portugal.
Rheumatology Department, Baixo Vouga Hospital Centre, 3810-164 Aveiro, Portugal.

Pedro L Ferreira (PL)

Centre for Health Studies and Research, Faculty of Economics, University of Coimbra, 3004-512 Coimbra, Portugal.

Tânia Santiago (T)

Rheumatology Department, Hospital and University Centre of Coimbra, 3004-512 Coimbra, Portugal.

Adriana Carones (A)

Rheumatology Department, Hospital and University Centre of Coimbra, 3004-512 Coimbra, Portugal.

Carolina Mazeda (C)

Rheumatology Department, Baixo Vouga Hospital Centre, 3810-164 Aveiro, Portugal.
EpiDoC Unit, CEDOC, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal.

Anabela Barcelos (A)

Rheumatology Department, Baixo Vouga Hospital Centre, 3810-164 Aveiro, Portugal.
EpiDoC Unit, CEDOC, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal.
Comprehensive Health Research Center (CHRC), NOVA University of Lisbon, 1169-056 Lisbon, Portugal.

Tiago Beirão (T)

Rheumatology Department, Vila Nova de Gaia Espinho Hospital Center, 4434-502 Vila Nova de Gaia, Portugal.

Flávio Costa (F)

Rheumatology Department, Vila Nova de Gaia Espinho Hospital Center, 4434-502 Vila Nova de Gaia, Portugal.

Inês Santos (I)

Rheumatology Department, Tondela Viseu Hospital Centre, 3504-509 Viseu, Portugal.

Maura Couto (M)

Rheumatology Department, Tondela Viseu Hospital Centre, 3504-509 Viseu, Portugal.

Maria Rato (M)

Rheumatology Department, Hospital Centre of São João, 4200-319 Porto, Portugal.

Georgina Terroso (G)

Rheumatology Department, Hospital Centre of São João, 4200-319 Porto, Portugal.

Paulo Monteiro (P)

Rheumatology Department, Tondela Viseu Hospital Centre, 3504-509 Viseu, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH